Targeting m<sup>6</sup>A RNA Modification in Tumor Therapeutics

Targeting m<sup>6</sup>A RNA Modification in Tumor Therapeutics

The prevalent eukaryotic RNA modification N6-methyladenosine (m<sup>6</sup>A), which is distributed in more than 50% of cases, has demonstrated significant implications in both normal development and disease progression, particularly in the context of cancer. This review aims to discuss...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhenwei Mao, Min Li, Shengjun Wang
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Current Oncology
Subjects:
N6-methyladenosine (m<sup>6</sup>A)
mRNA
tumor
targeting therapy
Online Access:https://www.mdpi.com/1718-7729/32/3/159
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items